nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—Alkylating Activity—Altretamine—ovarian cancer	0.248	0.465	CiPCiCtD
Estramustine—Alkylating Activity—Chlorambucil—ovarian cancer	0.143	0.267	CiPCiCtD
Estramustine—Alkylating Activity—Melphalan—ovarian cancer	0.143	0.267	CiPCiCtD
Estramustine—ESR1—ovarian cancer	0.115	0.702	CbGaD
Estramustine—MAP2—Paclitaxel—ovarian cancer	0.113	0.507	CbGbCtD
Estramustine—MAP2—Docetaxel—ovarian cancer	0.0815	0.367	CbGbCtD
Estramustine—ABCB1—ovarian cancer	0.0486	0.298	CbGaD
Estramustine—ABCB1—Topotecan—ovarian cancer	0.00619	0.0279	CbGbCtD
Estramustine—ABCB1—Vinorelbine—ovarian cancer	0.00436	0.0196	CbGbCtD
Estramustine—CYP3A4—Topotecan—ovarian cancer	0.00371	0.0167	CbGbCtD
Estramustine—ESR2—ovarian follicle—ovarian cancer	0.0035	0.12	CbGeAlD
Estramustine—ABCB1—Paclitaxel—ovarian cancer	0.00306	0.0138	CbGbCtD
Estramustine—CYP3A4—Vinorelbine—ovarian cancer	0.00261	0.0118	CbGbCtD
Estramustine—ESR1—ovarian follicle—ovarian cancer	0.0024	0.0823	CbGeAlD
Estramustine—ABCB1—Docetaxel—ovarian cancer	0.00222	0.00997	CbGbCtD
Estramustine—CYP3A4—Paclitaxel—ovarian cancer	0.00184	0.00826	CbGbCtD
Estramustine—ABCB1—Doxorubicin—ovarian cancer	0.00165	0.00743	CbGbCtD
Estramustine—ESR2—oviduct—ovarian cancer	0.00154	0.0528	CbGeAlD
Estramustine—MAP1A—myometrium—ovarian cancer	0.00134	0.0459	CbGeAlD
Estramustine—CYP3A4—Docetaxel—ovarian cancer	0.00133	0.00597	CbGbCtD
Estramustine—MAP1A—embryo—ovarian cancer	0.00129	0.0441	CbGeAlD
Estramustine—ESR1—oviduct—ovarian cancer	0.00105	0.0362	CbGeAlD
Estramustine—MAP1A—decidua—ovarian cancer	0.000992	0.034	CbGeAlD
Estramustine—CYP3A4—Doxorubicin—ovarian cancer	0.000989	0.00445	CbGbCtD
Estramustine—MAP1A—gonad—ovarian cancer	0.000873	0.03	CbGeAlD
Estramustine—MAP1A—uterus—ovarian cancer	0.000868	0.0298	CbGeAlD
Estramustine—MAP2—myometrium—ovarian cancer	0.00076	0.0261	CbGeAlD
Estramustine—MAP2—embryo—ovarian cancer	0.000731	0.0251	CbGeAlD
Estramustine—MAP1A—female gonad—ovarian cancer	0.00071	0.0243	CbGeAlD
Estramustine—MAP1A—vagina—ovarian cancer	0.000705	0.0242	CbGeAlD
Estramustine—MAP1A—testis—ovarian cancer	0.000629	0.0216	CbGeAlD
Estramustine—MAP2—uterine cervix—ovarian cancer	0.000592	0.0203	CbGeAlD
Estramustine—Myelosuppression—Vinorelbine—ovarian cancer	0.000564	0.0182	CcSEcCtD
Estramustine—MAP2—decidua—ovarian cancer	0.000564	0.0193	CbGeAlD
Estramustine—MAP2—endometrium—ovarian cancer	0.000535	0.0184	CbGeAlD
Estramustine—MAP2—gonad—ovarian cancer	0.000496	0.017	CbGeAlD
Estramustine—MAP1A—lymph node—ovarian cancer	0.000456	0.0157	CbGeAlD
Estramustine—MAP2—female reproductive system—ovarian cancer	0.000443	0.0152	CbGeAlD
Estramustine—Embolism—Vinorelbine—ovarian cancer	0.000412	0.0133	CcSEcCtD
Estramustine—Hoarseness—Paclitaxel—ovarian cancer	0.000405	0.0131	CcSEcCtD
Estramustine—MAP2—female gonad—ovarian cancer	0.000403	0.0138	CbGeAlD
Estramustine—MAP2—vagina—ovarian cancer	0.000401	0.0137	CbGeAlD
Estramustine—ESR2—epithelium—ovarian cancer	0.000387	0.0133	CbGeAlD
Estramustine—Raised liver function tests—Paclitaxel—ovarian cancer	0.000386	0.0124	CcSEcCtD
Estramustine—ESR2—uterine cervix—ovarian cancer	0.000383	0.0131	CbGeAlD
Estramustine—Leukopenia—Altretamine—ovarian cancer	0.000383	0.0123	CcSEcCtD
Estramustine—Myelosuppression—Paclitaxel—ovarian cancer	0.00038	0.0122	CcSEcCtD
Estramustine—MAP2—testis—ovarian cancer	0.000358	0.0123	CbGeAlD
Estramustine—ESR2—endometrium—ovarian cancer	0.000347	0.0119	CbGeAlD
Estramustine—Thrombocytopenia—Altretamine—ovarian cancer	0.000342	0.011	CcSEcCtD
Estramustine—ESR1—myometrium—ovarian cancer	0.000337	0.0116	CbGeAlD
Estramustine—Anorexia—Altretamine—ovarian cancer	0.000333	0.0107	CcSEcCtD
Estramustine—Night sweats—Paclitaxel—ovarian cancer	0.00033	0.0106	CcSEcCtD
Estramustine—Raised liver function tests—Docetaxel—ovarian cancer	0.000327	0.0105	CcSEcCtD
Estramustine—ESR1—embryo—ovarian cancer	0.000325	0.0111	CbGeAlD
Estramustine—Myelosuppression—Docetaxel—ovarian cancer	0.000322	0.0104	CcSEcCtD
Estramustine—ESR2—gonad—ovarian cancer	0.000322	0.011	CbGeAlD
Estramustine—Thromboembolism—Epirubicin—ovarian cancer	0.00032	0.0103	CcSEcCtD
Estramustine—ESR2—uterus—ovarian cancer	0.000319	0.011	CbGeAlD
Estramustine—Decreased appetite—Altretamine—ovarian cancer	0.000303	0.00979	CcSEcCtD
Estramustine—Thromboembolism—Doxorubicin—ovarian cancer	0.000296	0.00956	CcSEcCtD
Estramustine—Skin exfoliation—Melphalan—ovarian cancer	0.000289	0.00933	CcSEcCtD
Estramustine—ESR2—female reproductive system—ovarian cancer	0.000287	0.00985	CbGeAlD
Estramustine—Embolism—Paclitaxel—ovarian cancer	0.000277	0.00895	CcSEcCtD
Estramustine—ESR1—epithelium—ovarian cancer	0.000265	0.00908	CbGeAlD
Estramustine—ESR1—uterine cervix—ovarian cancer	0.000263	0.00901	CbGeAlD
Estramustine—ESR2—female gonad—ovarian cancer	0.000261	0.00896	CbGeAlD
Estramustine—ESR2—vagina—ovarian cancer	0.00026	0.00891	CbGeAlD
Estramustine—MAP2—lymph node—ovarian cancer	0.000259	0.00889	CbGeAlD
Estramustine—Quinestrol—ESR1—ovarian cancer	0.000258	0.163	CrCbGaD
Estramustine—Lacrimation—Docetaxel—ovarian cancer	0.000257	0.00828	CcSEcCtD
Estramustine—Skin exfoliation—Vinorelbine—ovarian cancer	0.000253	0.00815	CcSEcCtD
Estramustine—ESR1—decidua—ovarian cancer	0.00025	0.00858	CbGeAlD
Estramustine—ESR1—endometrium—ovarian cancer	0.000237	0.00815	CbGeAlD
Estramustine—Embolism—Docetaxel—ovarian cancer	0.000235	0.00758	CcSEcCtD
Estramustine—ESR2—testis—ovarian cancer	0.000232	0.00795	CbGeAlD
Estramustine—Lethargy—Topotecan—ovarian cancer	0.000229	0.00739	CcSEcCtD
Estramustine—Thrombophlebitis—Vinorelbine—ovarian cancer	0.000222	0.00716	CcSEcCtD
Estramustine—Vomiting—Altretamine—ovarian cancer	0.000222	0.00716	CcSEcCtD
Estramustine—ESR1—gonad—ovarian cancer	0.00022	0.00756	CbGeAlD
Estramustine—ESR1—uterus—ovarian cancer	0.000219	0.00751	CbGeAlD
Estramustine—Myelosuppression—Epirubicin—ovarian cancer	0.000217	0.007	CcSEcCtD
Estramustine—Dysphonia—Paclitaxel—ovarian cancer	0.000216	0.00698	CcSEcCtD
Estramustine—Cardiac arrest—Topotecan—ovarian cancer	0.000214	0.00689	CcSEcCtD
Estramustine—Cardiac arrest—Melphalan—ovarian cancer	0.000209	0.00675	CcSEcCtD
Estramustine—Nausea—Altretamine—ovarian cancer	0.000207	0.00669	CcSEcCtD
Estramustine—Pancytopenia—Chlorambucil—ovarian cancer	0.000207	0.00668	CcSEcCtD
Estramustine—Tenderness—Paclitaxel—ovarian cancer	0.000204	0.00658	CcSEcCtD
Estramustine—Liver function test abnormal—Melphalan—ovarian cancer	0.000203	0.00655	CcSEcCtD
Estramustine—Embolism venous—Epirubicin—ovarian cancer	0.000202	0.00651	CcSEcCtD
Estramustine—Myelosuppression—Doxorubicin—ovarian cancer	0.000201	0.00648	CcSEcCtD
Estramustine—ESR1—female reproductive system—ovarian cancer	0.000197	0.00675	CbGeAlD
Estramustine—Cerebrovascular accident—Vinorelbine—ovarian cancer	0.000196	0.00633	CcSEcCtD
Estramustine—Lethargy—Vinorelbine—ovarian cancer	0.000196	0.00633	CcSEcCtD
Estramustine—Mestranol—ESR1—ovarian cancer	0.000195	0.123	CrCbGaD
Estramustine—Hypernatraemia—Epirubicin—ovarian cancer	0.000194	0.00625	CcSEcCtD
Estramustine—Lacrimation increased—Paclitaxel—ovarian cancer	0.000193	0.00623	CcSEcCtD
Estramustine—Embolism venous—Doxorubicin—ovarian cancer	0.000187	0.00602	CcSEcCtD
Estramustine—Pancytopenia—Topotecan—ovarian cancer	0.000184	0.00595	CcSEcCtD
Estramustine—Pancytopenia—Melphalan—ovarian cancer	0.000181	0.00582	CcSEcCtD
Estramustine—Hypernatraemia—Doxorubicin—ovarian cancer	0.000179	0.00578	CcSEcCtD
Estramustine—ESR1—female gonad—ovarian cancer	0.000179	0.00614	CbGeAlD
Estramustine—ESR1—vagina—ovarian cancer	0.000178	0.0061	CbGeAlD
Estramustine—Lacrimation—Epirubicin—ovarian cancer	0.000173	0.00558	CcSEcCtD
Estramustine—Estriol—ESR1—ovarian cancer	0.000171	0.108	CrCbGaD
Estramustine—Skin exfoliation—Paclitaxel—ovarian cancer	0.00017	0.00548	CcSEcCtD
Estramustine—ESR2—lymph node—ovarian cancer	0.000168	0.00576	CbGeAlD
Estramustine—Lacrimation increased—Docetaxel—ovarian cancer	0.000164	0.00528	CcSEcCtD
Estramustine—Cramps of lower extremities—Paclitaxel—ovarian cancer	0.000164	0.00528	CcSEcCtD
Estramustine—Lacrimation—Doxorubicin—ovarian cancer	0.00016	0.00517	CcSEcCtD
Estramustine—ESR1—testis—ovarian cancer	0.000159	0.00545	CbGeAlD
Estramustine—Embolism—Epirubicin—ovarian cancer	0.000159	0.00512	CcSEcCtD
Estramustine—Pancytopenia—Vinorelbine—ovarian cancer	0.000158	0.00509	CcSEcCtD
Estramustine—Alopecia—Chlorambucil—ovarian cancer	0.000154	0.00498	CcSEcCtD
Estramustine—Thrombophlebitis—Paclitaxel—ovarian cancer	0.000149	0.00482	CcSEcCtD
Estramustine—Embolism—Doxorubicin—ovarian cancer	0.000147	0.00473	CcSEcCtD
Estramustine—Hypercalcaemia—Epirubicin—ovarian cancer	0.000147	0.00473	CcSEcCtD
Estramustine—Acute coronary syndrome—Vinorelbine—ovarian cancer	0.000146	0.00471	CcSEcCtD
Estramustine—Myocardial infarction—Vinorelbine—ovarian cancer	0.000145	0.00468	CcSEcCtD
Estramustine—Skin exfoliation—Docetaxel—ovarian cancer	0.000144	0.00465	CcSEcCtD
Estramustine—Eye pain—Paclitaxel—ovarian cancer	0.000143	0.00462	CcSEcCtD
Estramustine—Cardiac failure congestive—Paclitaxel—ovarian cancer	0.000143	0.0046	CcSEcCtD
Estramustine—Flushing—Melphalan—ovarian cancer	0.000141	0.00456	CcSEcCtD
Estramustine—Hot flush—Paclitaxel—ovarian cancer	0.000138	0.00446	CcSEcCtD
Estramustine—Alopecia—Topotecan—ovarian cancer	0.000137	0.00443	CcSEcCtD
Estramustine—Menopausal symptoms—Paclitaxel—ovarian cancer	0.000137	0.00442	CcSEcCtD
Estramustine—Leukopenia—Chlorambucil—ovarian cancer	0.000136	0.00439	CcSEcCtD
Estramustine—Hypercalcaemia—Doxorubicin—ovarian cancer	0.000136	0.00437	CcSEcCtD
Estramustine—Alopecia—Melphalan—ovarian cancer	0.000134	0.00434	CcSEcCtD
Estramustine—ABCB1—myometrium—ovarian cancer	0.000133	0.00457	CbGeAlD
Estramustine—Cerebrovascular accident—Paclitaxel—ovarian cancer	0.000132	0.00425	CcSEcCtD
Estramustine—Lethargy—Paclitaxel—ovarian cancer	0.000132	0.00425	CcSEcCtD
Estramustine—Estropipate—ESR1—ovarian cancer	0.00013	0.0823	CrCbGaD
Estramustine—Muscle spasms—Topotecan—ovarian cancer	0.00013	0.0042	CcSEcCtD
Estramustine—ABCB1—embryo—ovarian cancer	0.000128	0.0044	CbGeAlD
Estramustine—Thrombophlebitis—Docetaxel—ovarian cancer	0.000127	0.00408	CcSEcCtD
Estramustine—Dysphonia—Epirubicin—ovarian cancer	0.000124	0.00399	CcSEcCtD
Estramustine—Flushing—Vinorelbine—ovarian cancer	0.000123	0.00398	CcSEcCtD
Estramustine—Cardiac arrest—Paclitaxel—ovarian cancer	0.000123	0.00396	CcSEcCtD
Estramustine—Mood swings—Paclitaxel—ovarian cancer	0.000122	0.00395	CcSEcCtD
Estramustine—Thrombocytopenia—Chlorambucil—ovarian cancer	0.000121	0.00392	CcSEcCtD
Estramustine—Leukopenia—Topotecan—ovarian cancer	0.000121	0.00391	CcSEcCtD
Estramustine—Cardiac failure congestive—Docetaxel—ovarian cancer	0.000121	0.0039	CcSEcCtD
Estramustine—Estrone—CYP1B1—ovarian cancer	0.00012	0.0759	CrCbGaD
Estramustine—Liver function test abnormal—Paclitaxel—ovarian cancer	0.000119	0.00385	CcSEcCtD
Estramustine—Leukopenia—Melphalan—ovarian cancer	0.000119	0.00382	CcSEcCtD
Estramustine—Dry skin—Paclitaxel—ovarian cancer	0.000118	0.00382	CcSEcCtD
Estramustine—Anorexia—Chlorambucil—ovarian cancer	0.000118	0.00381	CcSEcCtD
Estramustine—Alopecia—Vinorelbine—ovarian cancer	0.000117	0.00379	CcSEcCtD
Estramustine—Hot flush—Docetaxel—ovarian cancer	0.000117	0.00378	CcSEcCtD
Estramustine—Menopausal symptoms—Docetaxel—ovarian cancer	0.000116	0.00375	CcSEcCtD
Estramustine—Chest pain—Topotecan—ovarian cancer	0.000115	0.00372	CcSEcCtD
Estramustine—ESR1—lymph node—ovarian cancer	0.000115	0.00395	CbGeAlD
Estramustine—Dysphonia—Doxorubicin—ovarian cancer	0.000114	0.00369	CcSEcCtD
Estramustine—Chest pain—Melphalan—ovarian cancer	0.000113	0.00364	CcSEcCtD
Estramustine—Lethargy—Docetaxel—ovarian cancer	0.000112	0.00361	CcSEcCtD
Estramustine—Lacrimation increased—Epirubicin—ovarian cancer	0.00011	0.00356	CcSEcCtD
Estramustine—CYP3A4—female reproductive system—ovarian cancer	0.00011	0.00377	CbGeAlD
Estramustine—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.00011	0.00353	CcSEcCtD
Estramustine—Oedema—Melphalan—ovarian cancer	0.000108	0.00349	CcSEcCtD
Estramustine—Thrombocytopenia—Topotecan—ovarian cancer	0.000108	0.00349	CcSEcCtD
Estramustine—Decreased appetite—Chlorambucil—ovarian cancer	0.000108	0.00348	CcSEcCtD
Estramustine—Pancytopenia—Paclitaxel—ovarian cancer	0.000106	0.00342	CcSEcCtD
Estramustine—Thrombocytopenia—Melphalan—ovarian cancer	0.000106	0.00341	CcSEcCtD
Estramustine—Anorexia—Topotecan—ovarian cancer	0.000105	0.00339	CcSEcCtD
Estramustine—ABCB1—epithelium—ovarian cancer	0.000105	0.00359	CbGeAlD
Estramustine—ABCB1—uterine cervix—ovarian cancer	0.000104	0.00356	CbGeAlD
Estramustine—Leukopenia—Vinorelbine—ovarian cancer	0.000104	0.00334	CcSEcCtD
Estramustine—Anorexia—Melphalan—ovarian cancer	0.000103	0.00332	CcSEcCtD
Estramustine—Lacrimation increased—Doxorubicin—ovarian cancer	0.000102	0.0033	CcSEcCtD
Estramustine—Liver function test abnormal—Docetaxel—ovarian cancer	0.000101	0.00326	CcSEcCtD
Estramustine—Dry skin—Docetaxel—ovarian cancer	0.0001	0.00324	CcSEcCtD
Estramustine—Depression—Paclitaxel—ovarian cancer	9.93e-05	0.0032	CcSEcCtD
Estramustine—ABCB1—decidua—ovarian cancer	9.88e-05	0.00339	CbGeAlD
Estramustine—Chest pain—Vinorelbine—ovarian cancer	9.85e-05	0.00318	CcSEcCtD
Estramustine—Dyspnoea—Topotecan—ovarian cancer	9.84e-05	0.00318	CcSEcCtD
Estramustine—Acute coronary syndrome—Paclitaxel—ovarian cancer	9.82e-05	0.00317	CcSEcCtD
Estramustine—Myocardial infarction—Paclitaxel—ovarian cancer	9.76e-05	0.00315	CcSEcCtD
Estramustine—Skin exfoliation—Epirubicin—ovarian cancer	9.72e-05	0.00314	CcSEcCtD
Estramustine—Dyspnoea—Melphalan—ovarian cancer	9.64e-05	0.00311	CcSEcCtD
Estramustine—Decreased appetite—Topotecan—ovarian cancer	9.6e-05	0.0031	CcSEcCtD
Estramustine—Decreased appetite—Melphalan—ovarian cancer	9.4e-05	0.00303	CcSEcCtD
Estramustine—ABCB1—endometrium—ovarian cancer	9.38e-05	0.00322	CbGeAlD
Estramustine—Cramps of lower extremities—Epirubicin—ovarian cancer	9.35e-05	0.00302	CcSEcCtD
Estramustine—Ethinyl Estradiol—ESR1—ovarian cancer	9.32e-05	0.0588	CrCbGaD
Estramustine—Thrombocytopenia—Vinorelbine—ovarian cancer	9.25e-05	0.00298	CcSEcCtD
Estramustine—Estradiol—CYP1B1—ovarian cancer	9.11e-05	0.0575	CrCbGaD
Estramustine—Anorexia—Vinorelbine—ovarian cancer	9e-05	0.0029	CcSEcCtD
Estramustine—Skin exfoliation—Doxorubicin—ovarian cancer	8.99e-05	0.0029	CcSEcCtD
Estramustine—Pancytopenia—Docetaxel—ovarian cancer	8.99e-05	0.0029	CcSEcCtD
Estramustine—Pruritus—Chlorambucil—ovarian cancer	8.77e-05	0.00283	CcSEcCtD
Estramustine—ABCB1—gonad—ovarian cancer	8.7e-05	0.00298	CbGeAlD
Estramustine—Cramps of lower extremities—Doxorubicin—ovarian cancer	8.65e-05	0.00279	CcSEcCtD
Estramustine—ABCB1—uterus—ovarian cancer	8.64e-05	0.00296	CbGeAlD
Estramustine—Thrombophlebitis—Epirubicin—ovarian cancer	8.54e-05	0.00275	CcSEcCtD
Estramustine—Diarrhoea—Chlorambucil—ovarian cancer	8.48e-05	0.00274	CcSEcCtD
Estramustine—Dyspnoea—Vinorelbine—ovarian cancer	8.42e-05	0.00272	CcSEcCtD
Estramustine—Tinnitus—Paclitaxel—ovarian cancer	8.34e-05	0.00269	CcSEcCtD
Estramustine—Acute coronary syndrome—Docetaxel—ovarian cancer	8.32e-05	0.00268	CcSEcCtD
Estramustine—Flushing—Paclitaxel—ovarian cancer	8.3e-05	0.00268	CcSEcCtD
Estramustine—Myocardial infarction—Docetaxel—ovarian cancer	8.27e-05	0.00267	CcSEcCtD
Estramustine—Decreased appetite—Vinorelbine—ovarian cancer	8.21e-05	0.00265	CcSEcCtD
Estramustine—Eye pain—Epirubicin—ovarian cancer	8.18e-05	0.00264	CcSEcCtD
Estramustine—Cardiac failure congestive—Epirubicin—ovarian cancer	8.15e-05	0.00263	CcSEcCtD
Estramustine—Conjugated Estrogens—ESR1—ovarian cancer	8.14e-05	0.0514	CrCbGaD
Estramustine—Estrone—ESR1—ovarian cancer	8.12e-05	0.0512	CrCbGaD
Estramustine—Alopecia—Paclitaxel—ovarian cancer	7.9e-05	0.00255	CcSEcCtD
Estramustine—Hot flush—Epirubicin—ovarian cancer	7.9e-05	0.00255	CcSEcCtD
Estramustine—Thrombophlebitis—Doxorubicin—ovarian cancer	7.9e-05	0.00255	CcSEcCtD
Estramustine—Vomiting—Chlorambucil—ovarian cancer	7.88e-05	0.00254	CcSEcCtD
Estramustine—Menopausal symptoms—Epirubicin—ovarian cancer	7.83e-05	0.00253	CcSEcCtD
Estramustine—Pruritus—Topotecan—ovarian cancer	7.81e-05	0.00252	CcSEcCtD
Estramustine—ABCB1—female reproductive system—ovarian cancer	7.77e-05	0.00267	CbGeAlD
Estramustine—Flatulence—Paclitaxel—ovarian cancer	7.67e-05	0.00247	CcSEcCtD
Estramustine—Pruritus—Melphalan—ovarian cancer	7.65e-05	0.00247	CcSEcCtD
Estramustine—Eye pain—Doxorubicin—ovarian cancer	7.57e-05	0.00244	CcSEcCtD
Estramustine—Diarrhoea—Topotecan—ovarian cancer	7.55e-05	0.00244	CcSEcCtD
Estramustine—Cerebrovascular accident—Epirubicin—ovarian cancer	7.54e-05	0.00243	CcSEcCtD
Estramustine—Lethargy—Epirubicin—ovarian cancer	7.54e-05	0.00243	CcSEcCtD
Estramustine—Cardiac failure congestive—Doxorubicin—ovarian cancer	7.54e-05	0.00243	CcSEcCtD
Estramustine—Muscle spasms—Paclitaxel—ovarian cancer	7.48e-05	0.00241	CcSEcCtD
Estramustine—Diarrhoea—Melphalan—ovarian cancer	7.4e-05	0.00239	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	7.39e-05	0.00238	CcSEcCtD
Estramustine—Nausea—Chlorambucil—ovarian cancer	7.37e-05	0.00238	CcSEcCtD
Estramustine—ABCB1—bone marrow—ovarian cancer	7.33e-05	0.00252	CbGeAlD
Estramustine—Hot flush—Doxorubicin—ovarian cancer	7.31e-05	0.00236	CcSEcCtD
Estramustine—Testosterone—CYP1B1—ovarian cancer	7.31e-05	0.0461	CrCbGaD
Estramustine—Affect lability—Epirubicin—ovarian cancer	7.27e-05	0.00235	CcSEcCtD
Estramustine—Estriol—ABCB1—ovarian cancer	7.25e-05	0.0457	CrCbGaD
Estramustine—Menopausal symptoms—Doxorubicin—ovarian cancer	7.25e-05	0.00234	CcSEcCtD
Estramustine—ABCB1—female gonad—ovarian cancer	7.07e-05	0.00243	CbGeAlD
Estramustine—Flushing—Docetaxel—ovarian cancer	7.03e-05	0.00227	CcSEcCtD
Estramustine—ABCB1—vagina—ovarian cancer	7.03e-05	0.00241	CbGeAlD
Estramustine—Cardiac arrest—Epirubicin—ovarian cancer	7.03e-05	0.00227	CcSEcCtD
Estramustine—Vomiting—Topotecan—ovarian cancer	7.02e-05	0.00226	CcSEcCtD
Estramustine—Mood swings—Epirubicin—ovarian cancer	7e-05	0.00226	CcSEcCtD
Estramustine—Lethargy—Doxorubicin—ovarian cancer	6.98e-05	0.00225	CcSEcCtD
Estramustine—Cerebrovascular accident—Doxorubicin—ovarian cancer	6.98e-05	0.00225	CcSEcCtD
Estramustine—Leukopenia—Paclitaxel—ovarian cancer	6.97e-05	0.00225	CcSEcCtD
Estramustine—Rash—Topotecan—ovarian cancer	6.96e-05	0.00225	CcSEcCtD
Estramustine—Dermatitis—Topotecan—ovarian cancer	6.95e-05	0.00224	CcSEcCtD
Estramustine—Headache—Topotecan—ovarian cancer	6.92e-05	0.00223	CcSEcCtD
Estramustine—Vomiting—Melphalan—ovarian cancer	6.87e-05	0.00222	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	6.84e-05	0.00221	CcSEcCtD
Estramustine—Liver function test abnormal—Epirubicin—ovarian cancer	6.82e-05	0.0022	CcSEcCtD
Estramustine—Rash—Melphalan—ovarian cancer	6.82e-05	0.0022	CcSEcCtD
Estramustine—Dermatitis—Melphalan—ovarian cancer	6.81e-05	0.0022	CcSEcCtD
Estramustine—Dry skin—Epirubicin—ovarian cancer	6.77e-05	0.00218	CcSEcCtD
Estramustine—Affect lability—Doxorubicin—ovarian cancer	6.73e-05	0.00217	CcSEcCtD
Estramustine—Alopecia—Docetaxel—ovarian cancer	6.7e-05	0.00216	CcSEcCtD
Estramustine—Pruritus—Vinorelbine—ovarian cancer	6.68e-05	0.00216	CcSEcCtD
Estramustine—Chest pain—Paclitaxel—ovarian cancer	6.63e-05	0.00214	CcSEcCtD
Estramustine—Anxiety—Paclitaxel—ovarian cancer	6.6e-05	0.00213	CcSEcCtD
Estramustine—Nausea—Topotecan—ovarian cancer	6.56e-05	0.00212	CcSEcCtD
Estramustine—Cardiac arrest—Doxorubicin—ovarian cancer	6.5e-05	0.0021	CcSEcCtD
Estramustine—Mood swings—Doxorubicin—ovarian cancer	6.48e-05	0.00209	CcSEcCtD
Estramustine—Diarrhoea—Vinorelbine—ovarian cancer	6.46e-05	0.00208	CcSEcCtD
Estramustine—Nausea—Melphalan—ovarian cancer	6.42e-05	0.00207	CcSEcCtD
Estramustine—Oedema—Paclitaxel—ovarian cancer	6.35e-05	0.00205	CcSEcCtD
Estramustine—Muscle spasms—Docetaxel—ovarian cancer	6.34e-05	0.00205	CcSEcCtD
Estramustine—Liver function test abnormal—Doxorubicin—ovarian cancer	6.31e-05	0.00204	CcSEcCtD
Estramustine—ABCB1—testis—ovarian cancer	6.27e-05	0.00215	CbGeAlD
Estramustine—Dry skin—Doxorubicin—ovarian cancer	6.27e-05	0.00202	CcSEcCtD
Estramustine—Thrombocytopenia—Paclitaxel—ovarian cancer	6.22e-05	0.00201	CcSEcCtD
Estramustine—Estradiol—ESR1—ovarian cancer	6.15e-05	0.0388	CrCbGaD
Estramustine—Pancytopenia—Epirubicin—ovarian cancer	6.06e-05	0.00196	CcSEcCtD
Estramustine—Anorexia—Paclitaxel—ovarian cancer	6.05e-05	0.00195	CcSEcCtD
Estramustine—Vomiting—Vinorelbine—ovarian cancer	6e-05	0.00194	CcSEcCtD
Estramustine—Rash—Vinorelbine—ovarian cancer	5.95e-05	0.00192	CcSEcCtD
Estramustine—Dermatitis—Vinorelbine—ovarian cancer	5.95e-05	0.00192	CcSEcCtD
Estramustine—Headache—Vinorelbine—ovarian cancer	5.92e-05	0.00191	CcSEcCtD
Estramustine—Leukopenia—Docetaxel—ovarian cancer	5.9e-05	0.00191	CcSEcCtD
Estramustine—Insomnia—Paclitaxel—ovarian cancer	5.74e-05	0.00185	CcSEcCtD
Estramustine—Dyspnoea—Paclitaxel—ovarian cancer	5.66e-05	0.00183	CcSEcCtD
Estramustine—Chest pain—Docetaxel—ovarian cancer	5.62e-05	0.00181	CcSEcCtD
Estramustine—Pancytopenia—Doxorubicin—ovarian cancer	5.61e-05	0.00181	CcSEcCtD
Estramustine—Nausea—Vinorelbine—ovarian cancer	5.61e-05	0.00181	CcSEcCtD
Estramustine—Decreased appetite—Paclitaxel—ovarian cancer	5.52e-05	0.00178	CcSEcCtD
Estramustine—Oedema—Docetaxel—ovarian cancer	5.38e-05	0.00174	CcSEcCtD
Estramustine—Thrombocytopenia—Docetaxel—ovarian cancer	5.27e-05	0.0017	CcSEcCtD
Estramustine—Anorexia—Docetaxel—ovarian cancer	5.13e-05	0.00166	CcSEcCtD
Estramustine—Insomnia—Docetaxel—ovarian cancer	4.87e-05	0.00157	CcSEcCtD
Estramustine—Dyspnoea—Docetaxel—ovarian cancer	4.8e-05	0.00155	CcSEcCtD
Estramustine—Tinnitus—Epirubicin—ovarian cancer	4.77e-05	0.00154	CcSEcCtD
Estramustine—Flushing—Epirubicin—ovarian cancer	4.74e-05	0.00153	CcSEcCtD
Estramustine—Decreased appetite—Docetaxel—ovarian cancer	4.68e-05	0.00151	CcSEcCtD
Estramustine—ABCB1—lymph node—ovarian cancer	4.54e-05	0.00156	CbGeAlD
Estramustine—Alopecia—Epirubicin—ovarian cancer	4.52e-05	0.00146	CcSEcCtD
Estramustine—Pruritus—Paclitaxel—ovarian cancer	4.49e-05	0.00145	CcSEcCtD
Estramustine—Tinnitus—Doxorubicin—ovarian cancer	4.41e-05	0.00142	CcSEcCtD
Estramustine—Flushing—Doxorubicin—ovarian cancer	4.39e-05	0.00142	CcSEcCtD
Estramustine—Flatulence—Epirubicin—ovarian cancer	4.38e-05	0.00141	CcSEcCtD
Estramustine—Diarrhoea—Paclitaxel—ovarian cancer	4.35e-05	0.0014	CcSEcCtD
Estramustine—Muscle spasms—Epirubicin—ovarian cancer	4.28e-05	0.00138	CcSEcCtD
Estramustine—Alopecia—Doxorubicin—ovarian cancer	4.18e-05	0.00135	CcSEcCtD
Estramustine—Flatulence—Doxorubicin—ovarian cancer	4.06e-05	0.00131	CcSEcCtD
Estramustine—Vomiting—Paclitaxel—ovarian cancer	4.04e-05	0.0013	CcSEcCtD
Estramustine—Rash—Paclitaxel—ovarian cancer	4e-05	0.00129	CcSEcCtD
Estramustine—Dermatitis—Paclitaxel—ovarian cancer	4e-05	0.00129	CcSEcCtD
Estramustine—Leukopenia—Epirubicin—ovarian cancer	3.98e-05	0.00128	CcSEcCtD
Estramustine—Headache—Paclitaxel—ovarian cancer	3.98e-05	0.00128	CcSEcCtD
Estramustine—Ethinyl Estradiol—ABCB1—ovarian cancer	3.96e-05	0.025	CrCbGaD
Estramustine—Muscle spasms—Doxorubicin—ovarian cancer	3.96e-05	0.00128	CcSEcCtD
Estramustine—Pruritus—Docetaxel—ovarian cancer	3.81e-05	0.00123	CcSEcCtD
Estramustine—Chest pain—Epirubicin—ovarian cancer	3.79e-05	0.00122	CcSEcCtD
Estramustine—Anxiety—Epirubicin—ovarian cancer	3.77e-05	0.00122	CcSEcCtD
Estramustine—Nausea—Paclitaxel—ovarian cancer	3.77e-05	0.00122	CcSEcCtD
Estramustine—Leukopenia—Doxorubicin—ovarian cancer	3.69e-05	0.00119	CcSEcCtD
Estramustine—Diarrhoea—Docetaxel—ovarian cancer	3.68e-05	0.00119	CcSEcCtD
Estramustine—Oedema—Epirubicin—ovarian cancer	3.63e-05	0.00117	CcSEcCtD
Estramustine—Thrombocytopenia—Epirubicin—ovarian cancer	3.56e-05	0.00115	CcSEcCtD
Estramustine—Chest pain—Doxorubicin—ovarian cancer	3.51e-05	0.00113	CcSEcCtD
Estramustine—Anxiety—Doxorubicin—ovarian cancer	3.49e-05	0.00113	CcSEcCtD
Estramustine—Anorexia—Epirubicin—ovarian cancer	3.46e-05	0.00112	CcSEcCtD
Estramustine—Conjugated Estrogens—ABCB1—ovarian cancer	3.46e-05	0.0218	CrCbGaD
Estramustine—Estrone—ABCB1—ovarian cancer	3.45e-05	0.0218	CrCbGaD
Estramustine—Vomiting—Docetaxel—ovarian cancer	3.42e-05	0.0011	CcSEcCtD
Estramustine—Rash—Docetaxel—ovarian cancer	3.39e-05	0.0011	CcSEcCtD
Estramustine—Dermatitis—Docetaxel—ovarian cancer	3.39e-05	0.00109	CcSEcCtD
Estramustine—Headache—Docetaxel—ovarian cancer	3.37e-05	0.00109	CcSEcCtD
Estramustine—Oedema—Doxorubicin—ovarian cancer	3.36e-05	0.00108	CcSEcCtD
Estramustine—Thrombocytopenia—Doxorubicin—ovarian cancer	3.29e-05	0.00106	CcSEcCtD
Estramustine—Insomnia—Epirubicin—ovarian cancer	3.28e-05	0.00106	CcSEcCtD
Estramustine—Dyspnoea—Epirubicin—ovarian cancer	3.24e-05	0.00104	CcSEcCtD
Estramustine—Anorexia—Doxorubicin—ovarian cancer	3.2e-05	0.00103	CcSEcCtD
Estramustine—Nausea—Docetaxel—ovarian cancer	3.2e-05	0.00103	CcSEcCtD
Estramustine—Decreased appetite—Epirubicin—ovarian cancer	3.16e-05	0.00102	CcSEcCtD
Estramustine—Insomnia—Doxorubicin—ovarian cancer	3.04e-05	0.00098	CcSEcCtD
Estramustine—ESR1—Leptin signaling pathway—ERBB2—ovarian cancer	3.03e-05	0.00153	CbGpPWpGaD
Estramustine—Dyspnoea—Doxorubicin—ovarian cancer	3e-05	0.000966	CcSEcCtD
Estramustine—ESR1—Leptin signaling pathway—MTOR—ovarian cancer	2.99e-05	0.00151	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—IL2—ovarian cancer	2.97e-05	0.0015	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—CDKN1B—ovarian cancer	2.96e-05	0.0015	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—ovarian cancer	2.95e-05	0.0015	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	2.93e-05	0.00148	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	2.92e-05	0.00148	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	2.92e-05	0.00148	CbGpPWpGaD
Estramustine—Decreased appetite—Doxorubicin—ovarian cancer	2.92e-05	0.000942	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—IL2—ovarian cancer	2.9e-05	0.00147	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—CCND1—ovarian cancer	2.89e-05	0.00146	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	2.84e-05	0.00144	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—CCND1—ovarian cancer	2.83e-05	0.00143	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—CTNNB1—ovarian cancer	2.8e-05	0.00142	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—TP53—ovarian cancer	2.75e-05	0.00139	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—MMP9—ovarian cancer	2.74e-05	0.00139	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—HRAS—ovarian cancer	2.73e-05	0.00138	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—PTEN—ovarian cancer	2.73e-05	0.00138	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—TERT—ovarian cancer	2.71e-05	0.00137	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—CCND1—ovarian cancer	2.67e-05	0.00135	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—MAPK3—ovarian cancer	2.67e-05	0.00135	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	2.64e-05	0.00134	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	2.63e-05	0.00133	CbGpPWpGaD
Estramustine—Estradiol—ABCB1—ovarian cancer	2.61e-05	0.0165	CrCbGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	2.58e-05	0.00131	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	2.57e-05	0.0013	CbGpPWpGaD
Estramustine—Pruritus—Epirubicin—ovarian cancer	2.57e-05	0.000829	CcSEcCtD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	2.56e-05	0.0013	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	2.56e-05	0.0013	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	2.56e-05	0.0013	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—MAPK1—ovarian cancer	2.54e-05	0.00129	CbGpPWpGaD
Estramustine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	2.52e-05	0.00128	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	2.51e-05	0.00127	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	2.51e-05	0.00127	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	2.49e-05	0.00126	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	2.49e-05	0.00126	CbGpPWpGaD
Estramustine—Diarrhoea—Epirubicin—ovarian cancer	2.48e-05	0.000802	CcSEcCtD
Estramustine—ESR1—Gene Expression—WDR77—ovarian cancer	2.46e-05	0.00125	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—MYC—ovarian cancer	2.43e-05	0.00123	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	2.42e-05	0.00123	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—AKT1—ovarian cancer	2.41e-05	0.00122	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—MAPK3—ovarian cancer	2.38e-05	0.00121	CbGpPWpGaD
Estramustine—Pruritus—Doxorubicin—ovarian cancer	2.38e-05	0.000767	CcSEcCtD
Estramustine—ESR1—Regulation of Telomerase—MYC—ovarian cancer	2.32e-05	0.00117	CbGpPWpGaD
Estramustine—Vomiting—Epirubicin—ovarian cancer	2.31e-05	0.000745	CcSEcCtD
Estramustine—ESR1—Leptin signaling pathway—STAT3—ovarian cancer	2.31e-05	0.00117	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—IL6ST—ovarian cancer	2.3e-05	0.00117	CbGpPWpGaD
Estramustine—Diarrhoea—Doxorubicin—ovarian cancer	2.3e-05	0.000742	CcSEcCtD
Estramustine—Rash—Epirubicin—ovarian cancer	2.29e-05	0.000739	CcSEcCtD
Estramustine—Dermatitis—Epirubicin—ovarian cancer	2.29e-05	0.000738	CcSEcCtD
Estramustine—Headache—Epirubicin—ovarian cancer	2.27e-05	0.000734	CcSEcCtD
Estramustine—ESR1—Regulation of Telomerase—MAPK1—ovarian cancer	2.27e-05	0.00115	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—EGFR—ovarian cancer	2.27e-05	0.00115	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—MYC—ovarian cancer	2.27e-05	0.00115	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—MAPK3—ovarian cancer	2.2e-05	0.00112	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2.19e-05	0.00111	CbGpPWpGaD
Estramustine—Nausea—Epirubicin—ovarian cancer	2.16e-05	0.000696	CcSEcCtD
Estramustine—Vomiting—Doxorubicin—ovarian cancer	2.14e-05	0.000689	CcSEcCtD
Estramustine—Rash—Doxorubicin—ovarian cancer	2.12e-05	0.000684	CcSEcCtD
Estramustine—Dermatitis—Doxorubicin—ovarian cancer	2.12e-05	0.000683	CcSEcCtD
Estramustine—Headache—Doxorubicin—ovarian cancer	2.1e-05	0.000679	CcSEcCtD
Estramustine—ESR1—Leptin signaling pathway—MAPK1—ovarian cancer	2.1e-05	0.00106	CbGpPWpGaD
Estramustine—Testosterone—ABCB1—ovarian cancer	2.1e-05	0.0132	CrCbGaD
Estramustine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ovarian cancer	2.08e-05	0.00106	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—YAP1—ovarian cancer	2.08e-05	0.00105	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	2.07e-05	0.00105	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.07e-05	0.00105	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	2.05e-05	0.00104	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	2.02e-05	0.00102	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.01e-05	0.00102	CbGpPWpGaD
Estramustine—Nausea—Doxorubicin—ovarian cancer	2e-05	0.000644	CcSEcCtD
Estramustine—ESR2—Gene Expression—YAP1—ovarian cancer	1.99e-05	0.00101	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.97e-05	0.000998	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.97e-05	0.000998	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—IL6—ovarian cancer	1.95e-05	0.000989	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PIK3CD—ovarian cancer	1.95e-05	0.000986	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—TTF1—ovarian cancer	1.93e-05	0.000979	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—ESR1—ovarian cancer	1.92e-05	0.000974	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HSD17B6—ovarian cancer	1.88e-05	0.000954	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TP53—ovarian cancer	1.86e-05	0.000943	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.86e-05	0.000942	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	1.84e-05	0.000935	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—PGR—ovarian cancer	1.82e-05	0.00092	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	1.81e-05	0.000915	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL6—ovarian cancer	1.78e-05	0.000901	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NR5A1—ovarian cancer	1.76e-05	0.000889	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PGR—ovarian cancer	1.73e-05	0.000878	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—ERBB2—ovarian cancer	1.72e-05	0.000871	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.71e-05	0.000866	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	1.71e-05	0.000864	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—IL6—ovarian cancer	1.7e-05	0.000863	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PIK3CB—ovarian cancer	1.7e-05	0.00086	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—MTOR—ovarian cancer	1.7e-05	0.00086	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—PARP1—ovarian cancer	1.69e-05	0.000855	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—HRAS—ovarian cancer	1.68e-05	0.000853	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.65e-05	0.000838	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	1.65e-05	0.000836	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PARP1—ovarian cancer	1.61e-05	0.000817	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—AKT1—ovarian cancer	1.61e-05	0.000815	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—DLC1—ovarian cancer	1.6e-05	0.000812	CbGpPWpGaD
Estramustine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	1.59e-05	0.000808	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—CDKN1B—ovarian cancer	1.59e-05	0.000807	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	1.57e-05	0.000795	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	1.55e-05	0.000783	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	1.53e-05	0.000774	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	1.51e-05	0.000766	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—AKT1—ovarian cancer	1.49e-05	0.000753	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	1.47e-05	0.000747	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PTEN—ovarian cancer	1.47e-05	0.000743	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	1.46e-05	0.000738	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.43e-05	0.000726	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	1.4e-05	0.000708	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	1.4e-05	0.000708	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.4e-05	0.000707	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	1.39e-05	0.000706	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CASP3—ovarian cancer	1.39e-05	0.000706	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL2—ovarian cancer	1.39e-05	0.000705	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	1.37e-05	0.000692	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	1.35e-05	0.000686	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	1.34e-05	0.000677	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	1.33e-05	0.000675	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	1.33e-05	0.000674	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.33e-05	0.000672	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—NRAS—ovarian cancer	1.31e-05	0.000663	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PPP2R1A—ovarian cancer	1.31e-05	0.000662	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—BCL9—ovarian cancer	1.31e-05	0.000662	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.3e-05	0.000659	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.27e-05	0.000641	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.25e-05	0.000635	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—MAPK3—ovarian cancer	1.25e-05	0.000635	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	1.23e-05	0.000621	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.22e-05	0.000619	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	1.2e-05	0.000607	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	1.2e-05	0.000607	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—MAPK1—ovarian cancer	1.19e-05	0.000604	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—EGFR—ovarian cancer	1.19e-05	0.000604	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	1.18e-05	0.000599	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	1.13e-05	0.000573	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—KRAS—ovarian cancer	1.13e-05	0.00057	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.1e-05	0.000559	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	1.1e-05	0.000558	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NME2—ovarian cancer	1.09e-05	0.000552	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	1.09e-05	0.00055	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	1.06e-05	0.000535	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.04e-05	0.000529	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PIK3CA—ovarian cancer	1.03e-05	0.000524	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	1.03e-05	0.000523	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—DOK1—ovarian cancer	1.03e-05	0.000523	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.02e-05	0.000514	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	1.01e-05	0.00051	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—YAP1—ovarian cancer	1e-05	0.000507	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—MYC—ovarian cancer	1e-05	0.000507	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	9.93e-06	0.000503	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	9.93e-06	0.000503	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	9.76e-06	0.000495	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PPP1CC—ovarian cancer	9.7e-06	0.000492	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—HRAS—ovarian cancer	9.57e-06	0.000485	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	9.38e-06	0.000475	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—ESR1—ovarian cancer	9.26e-06	0.000469	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—IL6—ovarian cancer	9.16e-06	0.000464	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PGR—ovarian cancer	8.74e-06	0.000443	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	8.72e-06	0.000442	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	8.62e-06	0.000437	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	8.5e-06	0.00043	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—AKT1—ovarian cancer	8.45e-06	0.000428	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.34e-06	0.000422	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PARP1—ovarian cancer	8.13e-06	0.000412	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	7.58e-06	0.000384	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HDAC6—ovarian cancer	7.35e-06	0.000373	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.05e-06	0.000357	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.04e-06	0.000357	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYTB—ovarian cancer	7.03e-06	0.000356	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	7.02e-06	0.000356	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	6.88e-06	0.000349	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	6.81e-06	0.000345	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NME2—ovarian cancer	6.72e-06	0.00034	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	6.7e-06	0.000339	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	6.63e-06	0.000336	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PPP2R1A—ovarian cancer	6.59e-06	0.000334	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—YAP1—ovarian cancer	6.51e-06	0.00033	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	6.46e-06	0.000327	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—XIAP—ovarian cancer	6.38e-06	0.000323	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SMARCA4—ovarian cancer	6.21e-06	0.000315	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—BRIP1—ovarian cancer	6.14e-06	0.000311	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PPP1CC—ovarian cancer	6.14e-06	0.000311	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EREG—ovarian cancer	6.07e-06	0.000307	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	5.84e-06	0.000296	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PGR—ovarian cancer	5.68e-06	0.000288	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	5.52e-06	0.00028	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	5.37e-06	0.000272	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PARP1—ovarian cancer	5.28e-06	0.000268	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	5.25e-06	0.000266	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	5.25e-06	0.000266	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—MYC—ovarian cancer	5.04e-06	0.000255	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	4.96e-06	0.000251	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—MAPK3—ovarian cancer	4.95e-06	0.000251	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—MYC—ovarian cancer	4.81e-06	0.000244	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	4.56e-06	0.000231	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	4.41e-06	0.000223	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYTB—ovarian cancer	4.33e-06	0.000219	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PPP2R1A—ovarian cancer	4.29e-06	0.000217	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—YAP1—ovarian cancer	4.12e-06	0.000209	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	3.78e-06	0.000192	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—BRIP1—ovarian cancer	3.78e-06	0.000192	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	3.72e-06	0.000189	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TERT—ovarian cancer	3.4e-06	0.000173	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—FASN—ovarian cancer	3.36e-06	0.00017	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—AKT1—ovarian cancer	3.34e-06	0.000169	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SLC5A5—ovarian cancer	3.3e-06	0.000167	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SLC2A1—ovarian cancer	3.19e-06	0.000162	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CAV1—ovarian cancer	3.15e-06	0.00016	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP1B1—ovarian cancer	3.06e-06	0.000155	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL6ST—ovarian cancer	2.99e-06	0.000151	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—APC—ovarian cancer	2.87e-06	0.000145	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CG—ovarian cancer	2.87e-06	0.000145	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	2.71e-06	0.000137	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—YAP1—ovarian cancer	2.54e-06	0.000129	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CD—ovarian cancer	2.52e-06	0.000128	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—MAPK3—ovarian cancer	2.5e-06	0.000126	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TYMS—ovarian cancer	2.47e-06	0.000125	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—MYC—ovarian cancer	2.43e-06	0.000123	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ERBB2—ovarian cancer	2.23e-06	0.000113	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CB—ovarian cancer	2.2e-06	0.000111	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MTOR—ovarian cancer	2.2e-06	0.000111	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCL8—ovarian cancer	2.11e-06	0.000107	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—FASN—ovarian cancer	2.07e-06	0.000105	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CDKN1B—ovarian cancer	2.06e-06	0.000105	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.03e-06	0.000103	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CASP3—ovarian cancer	2.02e-06	0.000102	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL2—ovarian cancer	2.02e-06	0.000102	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CAV1—ovarian cancer	1.99e-06	0.000101	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCND1—ovarian cancer	1.97e-06	9.97e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.97e-06	9.96e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CTNNB1—ovarian cancer	1.95e-06	9.87e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MMP9—ovarian cancer	1.91e-06	9.68e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTEN—ovarian cancer	1.9e-06	9.62e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.88e-06	9.54e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CG—ovarian cancer	1.82e-06	9.2e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—VEGFA—ovarian cancer	1.72e-06	8.69e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—STAT3—ovarian cancer	1.7e-06	8.61e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NRAS—ovarian cancer	1.69e-06	8.59e-05	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—AKT1—ovarian cancer	1.68e-06	8.53e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.67e-06	8.47e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MAPK3—ovarian cancer	1.62e-06	8.22e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CD—ovarian cancer	1.6e-06	8.08e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MYC—ovarian cancer	1.58e-06	8e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.55e-06	7.86e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MAPK1—ovarian cancer	1.54e-06	7.82e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EGFR—ovarian cancer	1.54e-06	7.82e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TYMS—ovarian cancer	1.52e-06	7.72e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KRAS—ovarian cancer	1.46e-06	7.39e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CB—ovarian cancer	1.39e-06	7.05e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CA—ovarian cancer	1.34e-06	6.79e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—ovarian cancer	1.3e-06	6.57e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HRAS—ovarian cancer	1.24e-06	6.28e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CAV1—ovarian cancer	1.23e-06	6.22e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTEN—ovarian cancer	1.2e-06	6.09e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL6—ovarian cancer	1.19e-06	6.01e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.12e-06	5.67e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKT1—ovarian cancer	1.09e-06	5.55e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	9.83e-07	4.98e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	8.57e-07	4.34e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CA—ovarian cancer	8.48e-07	4.3e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTEN—ovarian cancer	7.41e-07	3.75e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—AKT1—ovarian cancer	6.93e-07	3.51e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	5.22e-07	2.65e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—AKT1—ovarian cancer	4.27e-07	2.16e-05	CbGpPWpGaD
